ProteinIQ
Sign inStart for free
ProteinIQ
  1. Research evidence
  2. Structure Validation

3 min read

Apr '26

Tilapia amnoonvirus PB2 proteins validated with MolProbity

Researchers at Michigan State University used ProteinIQ's MolProbity app to validate predicted 3D structures of divergent amnoonvirus PB2 proteins from Egyptian Nile tilapia.

IQ

ProteinIQ Research evidence summary

Used ProteinIQThe methods section reports using the ProteinIQ MolProbity tool for structure validation.
Phylogenetic and Proteomic Analyses of Segment 2 Sequence Reveals the Presence of Two Variants of a Divergent Amnoonvirus (Family: Amnoonviridae) Infecting Nile Tilapia (Oreochromis niloticus)

El Asely A.M., Khalifa M.S., Xu W., Shaheen A.A., et al.

Microorganisms· 2026-02· Michigan State University

Tools used:Molprobity

The research

Tilapia lake virus (TiLV) has emerged as a serious threat to Nile tilapia aquaculture worldwide since its first description in 2006, and understanding its genetic diversity is essential for disease surveillance and control.

Researchers at Michigan State University and Benha University set out to characterize two newly sequenced variants of a divergent amnoonvirus - AmnoonvirusEGY1F and AmnoonvirusEGY1H - detected in farmed Nile tilapia in Egypt. Using Illumina sequencing, the team assembled full-length segment 2 sequences from both variants, which encode the PB2 subunit of the viral RNA-dependent RNA polymerase (RdRp), an enzyme central to viral replication and a key driver of pathogenicity and host immune evasion.

A core question of the study was whether the amino acid substitutions distinguishing the Egyptian variants from the TiLV index strain altered the 3D structure, function, or antigenicity of the PB2 protein. Answering that required reliable computational models as a starting point.

ProteinIQ in action

Before any mutation analysis could begin, the team had to confirm that the predicted protein structures were physically sound. The researchers generated 3D models of all three PB2 proteins using SWISS-MODEL, then faced a problem common in structural bioinformatics: computationally predicted models can contain geometric errors that look fine in a viewer but invalidate downstream comparisons. Structural differences between strains could easily reflect modeling artifacts rather than true biological divergence. They ran all three models through MolProbity to rule that out.

MolProbity assessed each model across three dimensions: the clash score (steric overlaps between atoms), Ramachandran statistics (backbone dihedral angle distributions), and rotamer outlier counts (correctness of sidechain conformations). These three metrics feed into a single MolProbity score that gives an overall measure of stereochemical quality comparable to experimental crystallography benchmarks. As the authors describe in their methods:

"This valuable tool collates multifaceted computational analyses to check for the overall geometric correctness of the predicted 3D protein structure and combine them into one value: the MolProbity score."

Once the models passed validation, the team used MolProbity's per-residue bond angle output to locate exactly where the Egyptian variants deviated structurally from TiLV. This granular report turned a pass/fail validation step into a map of structurally distinct sites across the three strains.

Key findings

All three predicted structures received MolProbity scores in the 1–2 range, reflecting the quality of high-resolution crystal structures: AmnoonvirusEGY1F scored 1.11, the TiLV index strain 1.12, and AmnoonvirusEGY1H 1.24. The bond angle analysis revealed meaningful differences at specific residues: deviations at six positions (C55–C57, C102–C103, C141–C142, C317–C318, C324–C325, and C331–C332) were present in the TiLV index strain but absent in both Egyptian variants, while deviations at C144 and C147 appeared only in the Egyptian strains. Sequence-level analysis identified 28 amino acid substitutions between the two Egyptian contigs, with two substitutions unique to AmnoonvirusEGY1H - A230E and A231T - predicted by SIFT and ConSurf to be functionally significant due to their location in a highly conserved region. FoldX energy calculations added further evidence, with predicted structure energies of 292.3 kcal/mol for TiLV, 282.89 for EGY1F, and 277.86 for EGY1H. The Egyptian variants are genetically and structurally distinct from known TiLV strains, a finding with direct implications for diagnostic assay design and disease notification decisions by animal health authorities.

Sources▼
  1. Phylogenetic and Proteomic Analyses of Segment 2 Sequence Reveals the Presence of Two Variants of a Divergent Amnoonvirus (Family: Amnoonviridae) Infecting Nile Tilapia (Oreochromis niloticus) Microorganisms · 2026. https://doi.org/10.3390/microorganisms14020343
Published
April 6, 2026

Table of contents

Cite this article

ProteinIQ (2026, April 6). Tilapia amnoonvirus PB2 proteins validated with MolProbity. https://proteiniq.io/customers/amnoonvirus-pb2-validation-molprobity

More research evidence

Antimicrobial Peptides

JUL '26

Insect antimicrobial peptide structures predicted with Chou-Fasman

Researchers used ProteinIQ's Chou-Fasman tool to predict secondary structures for five insect-derived antimicrobial peptide candidates before experimental testing.

Antibiotics Jiangsu Academy of Agricultural Sciences

Structure Prediction

MAY '26

Coa6-CoQ10 binding site modeled with Protenix

Researchers used Protenix to model how CoQ10 binds Coa6 in a mouse study of mitochondrial memory impairment.

Translational Neurodegeneration The Fourth Military Medical University

Peptide Analysis

APR '26

Anticancer plant peptides profiled with ProteinIQ

Researchers in Poland used ProteinIQ to compute physicochemical properties of bioactive peptides derived from in silico hydrolysis of anticancer plant antimicrobial peptides.

International Journal of Molecular Sciences University of Life Sciences in Lublin

ProteinIQ

© 2026 ProteinIQ

Products

  • Bioinformatics tools
  • Workflows
  • PDB viewer
  • API

Solutions

  • Small molecule
  • RNA discovery
  • Antibody engineering
  • Peptide discovery
  • Enzyme engineering
  • Protein engineering
  • Virtual screening
  • Molecular docking
  • Protein structure prediction
  • RNA structure prediction
  • Protein structure alignment
  • Protein design
  • Sequence alignment
  • Phylogenetic analysis
  • Molecular dynamics simulation

Resources

  • Documentation
  • Blog
  • Guides
  • Datasets
  • Changelog
  • Sitemap

Company

  • About
  • Contact
  • Enterprise
  • Pricing
  • Security
  • Trust center
  • Author
  • Legal
  • Terms
  • Privacy policy

Connect

  • LinkedIn
  • X
  • Discord
  • Pricing